Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bordetella pertussis whole cell antigen consists of entire killed bacteria containing all native antigens present on/in the pathogen. It elicits broad immune responses—both humoral and cellular—and has been foundational both in early vaccine development against whooping cough and current laboratory diagnostics/research applications. Its use provides comprehensive exposure to all potential protective epitopes found on Bordetella pertussis.
Induces humoral and cellular immune responses, leading to the production of antibodies and activation of T cells specific to Bordetella pertussis antigens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella pertussis Whole Cell Antigen.